P/E at 55.46 vs Industry's 63.05: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount to Industry P/E

The current P/E of 55.46 for Apollo Hospitals Enterprise Ltd. stands below the hospital sector’s average of 63.05, indicating the stock is trading at a roughly 12% discount to its peers. This valuation gap suggests the market is pricing in either a more cautious outlook on growth or risk factors specific to the company. Given the sector’s elevated P/E, which often reflects strong growth expectations, the discount could imply a relative value opportunity or a reflection of recent performance challenges. Apollo Hospitals’s premium was higher in previous years, making this current valuation a noteworthy shift.

Performance Across Timeframes: Momentum Divergence

Examining returns over multiple periods reveals a striking divergence. Over the past year, Apollo Hospitals has delivered a positive 6.93% return, outperforming the Sensex’s 10.91% decline. This outperformance extends to longer horizons, with three-year returns at 57.68% and five-year returns at 77.50%, both significantly ahead of the Sensex’s 10.24% and 21.10% respectively. Even the ten-year return of 492.16% dwarfs the Sensex’s 156.37%, underscoring the stock’s long-term strength.

However, the recent short-term trend is less encouraging. The stock has fallen 10.55% over the last three months, underperforming the Sensex’s 6.96% decline. The one-month and one-week returns are also negative at -8.20% and -10.19% respectively, compared to the Sensex’s -5.44% and -0.58%. The stock’s seven-day consecutive fall has resulted in an 11.13% loss, signalling a pronounced short-term weakness. Apollo Hospitals’s 1-day drop of 1.94% also contrasts with the Sensex’s 0.61% gain, highlighting recent volatility. Apollo Hospitals’s mixed momentum raises the question what is the current rating?

Moving Average Configuration: Signs of a Complex Trend

The technical setup for Apollo Hospitals reveals a nuanced picture. The stock currently trades above its 200-day moving average, a long-term bullish indicator, but remains below its 5-day, 20-day, 50-day, and 100-day moving averages. This configuration suggests that while the long-term trend remains intact, recent price action has been weak, with short and medium-term momentum faltering. The stock’s inability to sustain levels above these shorter moving averages points to a potential consolidation or correction phase within a broader uptrend. The seven-day losing streak and the 11.13% decline over this period reinforce this interpretation. Is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Context: Hospital Industry Performance

The hospital sector has experienced mixed results recently, with a combination of positive, flat, and negative performances across constituent stocks. The industry P/E of 63.05 remains elevated, reflecting continued investor optimism about healthcare demand and growth prospects. However, Apollo Hospitals’s valuation discount and recent underperformance relative to the sector suggest company-specific factors may be influencing sentiment. The sector’s broader resilience contrasts with the stock’s short-term weakness, highlighting the importance of analysing individual stock dynamics within the industry framework.

Rating Context: Previously Strong Buy, Now Reassessed

MarketsMOJO had previously rated Apollo Hospitals Enterprise Ltd. as Strong Buy, with a Mojo Score of 77.0. The rating was updated on 28 Sep 2026, reflecting the latest data on valuation, performance, and technical indicators. While the current rating is not disclosed, the reassessment acknowledges the evolving market conditions and the stock’s recent momentum shifts. This update invites investors to consider the full spectrum of data — from valuation discounts to moving average signals — when evaluating the stock’s prospects. Should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: A Data-Driven Perspective on Apollo Hospitals

The data on Apollo Hospitals Enterprise Ltd. reveals a stock trading at a valuation discount relative to its hospital industry peers, despite a long-term record of strong returns. The recent divergence between short-term weakness and longer-term outperformance, combined with a mixed moving average configuration, suggests a period of consolidation or correction within an overall positive trend. The sector’s elevated P/E and mixed performance backdrop add further complexity to the picture. The updated rating, following a previous Strong Buy, reflects these nuanced dynamics and invites a closer look at the evolving fundamentals and technical signals.